GLOBAL IV CATHETERS MARKET INSIGHTS

The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach USD 6.63 billion by 2029, growing at a CAGR of 5.04% during the forecast period. The market is growing steadily due to factors such as rising hospitalization rates, increased prevalence of diseases among the target population, and chemotherapy procedures requiring IV catheters to deliver medication, nutrition, and fluids to patients. The global IV catheters market is influenced by the increase in hospitalizations and the prevalence of acute and chronic diseases among people.

MARKET DEFINITION

IV therapy is one of the most widely used therapies in healthcare centers, wherein IV catheters are used to administer drugs, nutritional supplements, fluids, blood, and other medical products. IV catheters are classified into peripheral intravenous catheters (PIVCs) and central intravenous catheters (CIVCs).

MARKET DRIVERS

Expanding Population with Chronic & Lifestyle Diseases: Global population aging is evident, with nearly every country witnessing an increase in the proportion and size of the older demographic. The surge in the elderly population and the prevalence of chronic diseases is linked to unhealthy lifestyles and the extended average life expectancy globally. The continuous growth in individuals with chronic conditions and the rapidly expanding elderly population are the primary factors fueling the global demand for peripheral IV catheters.

Rise in Hospitalization Rate: Patients worldwide receive intravenous drugs and components, propelling the PIVCs market globally. Nearly all hospitalized patients undergo at least one peripheral intravenous catheter insertion, establishing them as widely used vascular devices for delivering medication, nutrients, and fluids. The primary driver for PIVC adoption is the rising incidence of chronic diseases in the elderly, leading to hospital admissions.

High Usage of CIVCs in Chemotherapy: Cancer, a chronic disease, necessitates regular drug and radiation therapy. Chemotherapy is often safely administered via a standard IV line, and infusions require a central lines catheter like PICCs, CVCs, or Implantable port. CVCs take precedence due to the limited safety of PIVCs for a few weeks, while CVCs are used for months or years until treatment concludes. To minimize infection risks and minimize cell and tissue damage, CIVCs are generally preferred over PIVCs.

GLOBAL IV CATHETERS MARKET HIGHLIGHTS

The PIVCs product segment holds the largest global IV catheters market share in 2023. The adoption of PIVCs is growing across the world due to the increasing hospital and intensive care admissions attributed to the rising aging population associated with various chronic and lifestyle diseases. Rising awareness about advanced visualization technologies that help properly insert PIVCs and reduce complications is a major contributor to adopting PIVCs.
Short PIVCs product segment had the highest peripheral IV catheters market size in 2023. Short PIVCs are the most widely used medical devices across various healthcare settings. The insertion of short PIVCs is one of the most performed invasive techniques in acute care settings. The use of short PIVCs is widespread among oncology patients, particularly in patients receiving IV medications in either inpatient or home care settings.
The conventional PIVCs technology segment accounted for a major share of the global peripheral intravenous catheters market. Conventional PIVCs are simple, inexpensive IV lines used for short-term intravenous therapy. These PIVCs allow safe infusion of medications, hydration fluids, blood products, and nutritional supplements.
The peripheral inserted central catheters (PICCs) product segment accounted for the highest market share of over 45% of the global CIVCs market. The market is growing faster due to the rising awareness regarding healthcare and increasing concern for needlestick injuries and rising bloodborne infections among users. The rise in the number of hospitalizations due to various reasons globally increases the demand for the PICC.
The multi-lumen design segment is growing at the highest CAGR of 6.55% from 2024 to 2029 in the global CIVCs market. The multi-lumen CIVCs provide multiple access to the central vein for intravenous therapy. The market is growing faster as they facilitate multiple channels to administer many drugs and minimize the frequency of catheter insertions in patients. This advantage is driving the usage of multi-lumen catheters among the end-users.
The acute usage segment accounted for a major share of the global CIVCs market. The acute use market is growing at a faster rate due to the increasing hospital admissions for short-term medication. The acute use of CIVCs is generally less than ten days, and this is due to increasing hospital admissions. Hence, this increase in hospital admissions due to the growing patient population drives the demand for CIVCs in the market.
The homecare settings end-user segment is expected to grow at the fastest CAGR of 6.19% from 2024 – 2029. Home-based care refers to services offered at home for supporting patients, including skilled services such as therapy and nursing, caregiving, and personal care services. Patients prefer homecare settings who have increased concern toward hospital-acquired infections prefer intravenous therapy at home, resulting in the growth of this segment.

GEOGRAPHICAL INSIGHTS

The U.S. accounted for a revenue share of over 92% of the North American IV catheters market. The rising elderly population with chronic illnesses, growing hospitalization rates, increased need for IV catheters for ICU and emergency patients, demand for advanced safety catheters, rising healthcare expenditures, higher accessibility to advanced healthcare, and health coverage have contributed to the growth of the PIVCs market in the U.S.
Italy is growing significantly in the European IV catheter market, with the fastest CAGR of 6.16% from 2024 – 2029. It is observed that there is an overuse of the emergency department by the pediatric population in developing countries such as Italy as well as worldwide. This phenomenon of overusing the emergency department is leading to increasing demand for advanced CIVCs to provide nutrients and drugs to the patients in the emergency care units.
India is the fastest-growing region in the APAC IV catheter market, with a CAGR of 6.06%. Various chronic diseases are fueling the hospitalization rates among the Indian population. These include cardiovascular diseases, stroke, respiratory diseases, tuberculosis, COPD, diabetes, Alzheimer’s disease, dementia, malaria, and others.
The IV catheters market in Brazil is one of the fastest-growing markets among all emerging economies and the largest in Latin America. The market is witnessing growth, mainly due to increased self-, government, and private expenditures in healthcare. On average, 50% of Brazil’s expenditure is financed by the government, 25% by private players, and 25% by individuals/patients.
Turkey leads the IV catheter market share in the Middle East & Africa, growing at a CAGR of 5.10% from 2024 - 2029. Turkey has a large patient population with various acute and chronic conditions, thereby witnessing a high demand for PIVCs in the country. For instance, in 2018, about 210,537 new cancer cases were recorded in Turkey. In addition, the elderly population in need of various healthcare services is increasing. This is the primary reason for the rise in the absolute number of hospital admissions, further driving the growth of the PIVCs market in the country.
The IV catheter market in South Africa is growing prominently, with a CAGR of 5.36% from 2024 to 2029. South Africa is home to many affordable surgical procedures. It is also popular as a medical tourism destination among its neighboring countries. The rise in the number of surgeries performed will increase the use of PIVCs in healthcare settings.

VENDOR LANDSCAPE

The global IV catheters market report contains exclusive data on 33 vendors. BD, B Braun, Terumo, Teleflex, ICU Medical, and Nipro Medical are some leading players currently dominating the global IV catheters market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the IV catheters market and gain access to commercially launched products.

U.S. Pharmacy Benefit Management Market - Focused Insights 2024-2029

Speak With Us

About The Report

U.S. PHARMACY BENEFIT MANAGEMENT MARKET INSIGHTS

U.S. PHARMACY BENEFIT MANAGEMENT MARKET HIGHLIGHTS

Client Oriented Solutions

Analytical Approach

Comprehensive Data Repository

Publication Analysis

Summary

Report Preview

Table Of Contents

CHAPTER – 1: Pharmacy Benefit Management Market Overview

CHAPTER – 6: Appendix

CHAPTER – 2: Pharmacy Benefit Management Market

CHAPTER – 3: Pharmacy Benefit Management Market Segmentation Data

CHAPTER – 4: Pharmacy Benefit Management Market Prospects & Opportunities

CHAPTER – 5: Pharmacy Benefit Management Industry Overview

List of Exhibits

List of Tables

Interested in this report?

Other Related Reports

Europe Cell & Gene Therapy Market - Focused Insights 2023-2028

Europe Wound Care Market - Focused Insights 2023-2028

US Wound Care Market - Focused Insights 2023-2028